Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: A meta-analysis

International Journal of Gynecological Cancer

Volumn 20, Issue 5, 2010, Pages 732-737

  Economopoulos, Konstantinos P ^a,b   Sergentanis, Theodoros N ^a,b   Vlahos, Nikos F ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Society of Junior Doctors   (Greece)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GSTM1; GSTP1 polymorphism; GSTT1; Meta analysis; Ovarian cancer; Ovarian tumors

Indexed keywords

GLUTATHIONE TRANSFERASE;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; DATA BASE; DNA POLYMORPHISM; ENZYME ACTIVITY; GENETIC RISK; GENOTYPE; HUMAN; MEDLINE; OVARY CANCER; PRIORITY JOURNAL;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 77956816039     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181dedeb5     Document Type: Article

References (29)

1. Coughlin SS, Hall IJ. Glutathione S-transferase polymorphisms and risk of ovarian cancer: A HuGE review. Genet Med. 2002;4:250Y257.
2. Cotton SC, Sharp L, Little J, et al. Glutathione S-transferase polymorphisms and colorectal cancer: A HuGE review. Am J Epidemiol. 2000;151:7Y32.
3. Bolt HM, Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab. 2006;7: 613Y628.
4. Raimondi S, Botteri E, Iodice S, et al. Gene-smoking interaction on colorectal adenoma and cancer risk: Review and meta-analysis. Mutat Res. 2009;670:6Y14.
5. Gao Y, Pan X, Su T, et al. Glutathione S-transferase P1 Ile105Val polymorphism and colorectal cancer risk: A meta-analysis and HuGE review. Eur J Cancer. 2009;45: 3303Y3314.
6. Dalhoff K, Buus Jensen K, Enghusen Poulsen H. Cancer and molecular biomarkers of phase 2. Methods Enzymol. 2005;400:618Y627.
7. Hengstler JG, Arand M, Herrero ME, et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility. Recent Results Cancer Res. 1998;154:47Y85.
8. Dong LM, Potter JD, White E, et al. Genetic susceptibility to cancer: The role of polymorphisms in candidate genes. JAMA. 2008;299:2423Y2436.
9. Johansson AS, Stenberg G, Widersten M, et al. Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol. 1998;278:687Y698.
10. Yu KD, Di GH, Fan L, et al. A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer. FASEB J. 2009;23:2274Y2287.
11. Sergentanis TN, Economopoulos KP. GSTT1 and GSTP1 polymorphisms and breast cancer risk: A meta-analysis. Breast Cancer Res Treat. September 17, 2009. [Epub ahead of print].
12. Hengstler JG, Kett A, Arand M, et al. Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Lett. 1998;130:43Y48.
13. Sarhanis P, Redman C, Perrett C, et al. Epithelial ovarian cancer: Influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression. Br J Cancer. 1996;74:1757Y1761.
14. Gates MA, Tworoger SS, Terry KL, et al. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:2436Y2444.
15. Morari EC, Lima AB, Bufalo NE, et al. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. J Cancer Res Clin Oncol. 2006;132:521Y528.
16. Spurdle AB, Webb PM, Purdie DM, et al. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: Risk of ovarian cancer by histological subtype. Carcinogenesis. 2001;22:67Y72.
17. Baxter SW, Thomas EJ, Campbell IG. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis. 2001;22:63Y65.
18. Lallas TA, McClain SK, Shahin MS, et al. The glutathione S-transferase M1 genotype in ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:587Y590.
19. Delort L, Chalabi N, Satih S, et al. Association between genetic polymorphisms and ovarian cancer risk. Anticancer Res. 2008;28:3079Y3081.
20. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557Y560.
21. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629Y634.
22. Sgambato A, Campisi B, Zupa A, et al. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res. 2002;22:3647Y3652.
23. Boccia S, La Torre G, Gianfagna F, et al. Glutathione S-transferase T1 status and gastric cancer risk: A meta-analysis of the literature. Mutagenesis. 2006;21:115Y123.
24. Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett. 2001;169:21Y26.
25. La Torre G, Boccia S, Ricciardi G. Glutathione S-transferase M1 status and gastric cancer risk: A meta-analysis. Cancer Lett. 2005;217:53Y60.
26. Carlsten C, Sagoo GS, Frodsham AJ, et al. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: A literature-based systematic HuGE review and meta-analysis. Am J Epidemiol. 2008;167:759Y774.
27. de Jong MM, Nolte IM, te Meerman GJ, et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 2002;11:1332Y1352.
28. Ye Z, Parry JM. A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit. 2003;9:SR83YSR91.
29. Raimondi S, Paracchini V, Autrup H, et al. Meta- and pooled analysis of GSTT1 and lung cancer: A HuGE-GSEC review. Am J Epidemiol. 2006;164:1027Y1042.